2016-2022

University research. 2 prototypes tested on 100+ patients. 1m EUR invested.

2022

Buildit accelerator Batch15 graduated. Idea validated.

February 2023

Obtained exclusive IP licence. Spinoff created.

May 2023

Joined Health Founders accelerator Batch IV.

January 2024

Secured convertible loan of 50’000 EUR from Commercialization Reactor (Latvia).

July 2024

Received 60’000 EUR R&D cascade funding grant.

July 2024

The first international demo on real patients (France, Hôpital Bicêtre).

July 2024

Joined Startupbootcamp DeepTech & Robotics Class 2024.

August 2024

EIT Health Innostars Awards finalist in Validation track.

July 2025

Graduated Medical Innovations Incubator 4C program (Tubingen, Germany).

September 2024

Joined Life Sciences Acceleration LSA program (Mannheim, Germany).

October 2025

52’500 EUR grant secured from the Latvian Investment and Development agency.

January 2026

Registered international headquarters (a new legal entity) in the United Kingdom.

February 2026

Accepted to NVIDIA Inception program to accelerate growth and AI development.